Silva Pharmaceuticals Limited (DSE:SILVAPHL)

Silva Pharmaceuticals Statistics

Total Valuation

DSE:SILVAPHL has a market cap or net worth of BDT 1.24 billion. The enterprise value is 1.14 billion.

Market Cap	1.24B
Enterprise Value	1.14B

Important Dates

The last earnings date was Tuesday, October 28, 2025.

Earnings Date	Oct 28, 2025
Ex-Dividend Date	Dec 2, 2024

Share Statistics

DSE:SILVAPHL has 136.50 million shares outstanding.

Current Share Class	136.50M
Shares Outstanding	136.50M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.24
PB Ratio	0.59
P/TBV Ratio	0.59
P/FCF Ratio	191.41
P/OCF Ratio	91.62
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-8.60
EV / Sales	2.98
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	176.16

Financial Position

The company has a current ratio of 14.90, with a Debt / Equity ratio of 0.01.

Current Ratio	14.90
Quick Ratio	5.97
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	4.87
Interest Coverage	-26.52

Financial Efficiency

Return on equity (ROE) is -6.09% and return on invested capital (ROIC) is -3.40%.

Return on Equity (ROE)	-6.09%
Return on Assets (ROA)	-3.24%
Return on Invested Capital (ROIC)	-3.40%
Return on Capital Employed (ROCE)	-5.51%
Revenue Per Employee	557,629
Profits Per Employee	-193,243
Employee Count	596
Asset Turnover	0.16
Inventory Turnover	0.60

Taxes

In the past 12 months, DSE:SILVAPHL has paid 13.37 million in taxes.

Income Tax	13.37M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -3.03% in the last 52 weeks. The beta is -0.05, so DSE:SILVAPHL's price volatility has been lower than the market average.

Beta (5Y)	-0.05
52-Week Price Change	-3.03%
50-Day Moving Average	11.53
200-Day Moving Average	10.82
Relative Strength Index (RSI)	33.37
Average Volume (20 Days)	190,471

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DSE:SILVAPHL had revenue of BDT 383.65 million and -132.95 million in losses. Loss per share was -0.97.

Revenue	383.65M
Gross Profit	102.47M
Operating Income	-121.01M
Pretax Income	-119.58M
Net Income	-132.95M
EBITDA	-61.71M
EBIT	-121.01M
Loss Per Share	-0.97

Balance Sheet

The company has 102.80 million in cash and 31.60 million in debt, giving a net cash position of 71.21 million or 0.52 per share.

Cash & Cash Equivalents	102.80M
Total Debt	31.60M
Net Cash	71.21M
Net Cash Per Share	0.52
Equity (Book Value)	2.11B
Book Value Per Share	15.48
Working Capital	774.14M

Cash Flow

In the last 12 months, operating cash flow was 13.56 million and capital expenditures -7.07 million, giving a free cash flow of 6.49 million.

Operating Cash Flow	13.56M
Capital Expenditures	-7.07M
Free Cash Flow	6.49M
FCF Per Share	0.05

Margins

Gross margin is 26.71%, with operating and profit margins of -31.54% and -34.65%.

Gross Margin	26.71%
Operating Margin	-31.54%
Pretax Margin	-31.17%
Profit Margin	-34.65%
EBITDA Margin	-16.09%
EBIT Margin	-31.54%
FCF Margin	1.69%

Dividends & Yields

This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 1.10%.

Dividend Per Share	0.10
Dividend Yield	1.10%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	1.06%
Earnings Yield	-10.70%
FCF Yield	0.52%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 7, 2019. It was a forward split with a ratio of 1.05.

Last Split Date	Nov 7, 2019
Split Type	Forward
Split Ratio	1.05

Scores

Altman Z-Score	n/a
Piotroski F-Score	3